Your browser doesn't support javascript.
loading
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration.
Sakemura, Reona; Terakura, Seitaro; Watanabe, Keisuke; Julamanee, Jakrawadee; Takagi, Erina; Miyao, Kotaro; Koyama, Daisuke; Goto, Tatsunori; Hanajiri, Ryo; Nishida, Tetsuya; Murata, Makoto; Kiyoi, Hitoshi.
Afiliación
  • Sakemura R; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan. tseit@med.nagoya-u.ac.jp.
  • Watanabe K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Julamanee J; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Division of Clinical Hematology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Takagi E; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Miyao K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Koyama D; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Goto T; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hanajiri R; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nishida T; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Murata M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Cancer Immunol Res ; 4(8): 658-68, 2016 08.
Article en En | MEDLINE | ID: mdl-27329987

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Receptores de Antígenos de Linfocitos T / Regulación de la Expresión Génica / Doxiciclina / Antígenos CD19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Receptores de Antígenos de Linfocitos T / Regulación de la Expresión Génica / Doxiciclina / Antígenos CD19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2016 Tipo del documento: Article País de afiliación: Japón